Genetics of variation in serum uric acid and cardiovascular risk factors in Mexican Americans

V Saroja Voruganti1, Subrata D Nath, Shelley A Cole

  • 1Department of Genetics, Southwest Foundation for Biomedical Research, P.O. Box 760549, San Antonio, Texas 78227, USA. svorugan@sfbrgenetics.org

Insights

Serum uric acid levels are significantly heritable in Mexican Americans, with genetic factors influencing its variation. This study identified a key genetic region on chromosome 3p26 linked to serum uric acid and cardiovascular disease risk factors.

Area of Science:

  • Genetics
  • Cardiovascular Disease Research
  • Metabolic Health

Background:

  • Elevated serum uric acid is linked to cardiovascular disease (CVD) risk factors like hypertension and obesity.
  • The independent role of uric acid in CVD development requires further clarification.

Purpose of the Study:

  • To identify quantitative trait loci (QTLs) influencing serum uric acid levels.
  • To examine the relationship between serum uric acid and other CVD risk factors in Mexican Americans.

Main Methods:

  • Quantitative genetic analysis using variance components decomposition (SOLAR software).
  • Genome-wide scan for QTL detection.
  • Bivariate analysis to assess correlations between serum uric acid and CVD risk markers.

Main Results:

  • Serum uric acid and CVD risk markers demonstrated significant heritability.
  • Significant correlations were found between serum uric acid and body mass index, waist circumference, body fat, insulin, triglycerides, HDL cholesterol, and inflammatory markers.
  • A significant QTL for serum uric acid variation was identified on chromosome 3p26 (LOD score 4.72), with chemokine receptor 2 as a candidate gene.

Conclusions:

  • Serum uric acid levels exhibit a substantial genetic influence on their variation.
  • Evidence suggests pleiotropy, where a single gene influences multiple traits, between serum uric acid and cardiovascular risk factors.
Abstract

Related Concept Videos

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Principles of Pharmacogenetics: Types of Genetic Variants01:27

Principles of Pharmacogenetics: Types of Genetic Variants

The human genome is over 99.9% identical between individuals, yet genetic differences exist at millions of bases. The human genome contains approximately 3 million variant positions per individual, many of which are heterozygous, contributing to genetic diversity and individual traits. Genetic variations include single-nucleotide polymorphisms (SNPs), insertions, deletions, and copy number variations (CNVs).SNPs, the most common variation, involve single-base changes in DNA. These can be...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...